Now showing items 1-1 of 1

    • Preclinical Evaluation of Dual mTOR Inhibitor, AZD2014, in Prostate Cancer 

      Sandi, Chiranjeevi; Ramos-Montoya, Antonio; Filisbino, Sergio L.; Jurmeister, Sarah; Basetti, Madhu; Wadhwa, Karan; Griffiths, John R. et al. (American Association for Cancer Research, 2015-11-05)
      Background: An estimated 220,800 cases and 27,540 deaths from prostate cancer (PCa) will occur in the USA during 2015. Altered PI3K/AKT/mTOR signalling contributes to prostate cancer progression and transition to ...